6..11  Comment:  The phrase “or othermethod approved by WADA” isintended to cover, for example,mobile blood Testing procedureswhich WADA has reviewed andconsiders to be reliable.20by WADA pursuant to Article 4.5 (Monitoring Program),without the Athlete’s written consent.6.4 Standards for Sample Analysis and ReportingLaboratories shall analyze Doping Control Samples andreport results in conformity with the InternationalStandard for laboratory analysis.ARTICLE  7:    RESULTS  MANAGEMENTEach Anti-Doping Organization conducting results management shallestablish a process for the pre-hearing administration of potentialanti-doping rule violations that respects the following principles:7.1 Initial Review Regarding Adverse Analytical FindingsUpon receipt of an A Sample Adverse Analytical Finding,the Anti-Doping Organization responsible for resultsmanagement shall conduct a review to determinewhether:  (a) an applicable therapeutic use exemption hasbeen granted, or (b) there is any apparent departure fromthe International Standards for Testing or laboratoryanalysis that undermines the validity of the AdverseAnalytical Finding.7.2 Notification After Initial ReviewIf the initial review under Article 7.1 does not reveal anapplicable therapeutic use exemption or departure thatundermines the validity of the Adverse Analytical Finding,7  Comment:    Various of the Signatorieshave created their own approaches toresults management for AdverseAnalytical Findings.